Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
Select bar for recommendation details.
Recommendations | 14-Nov-24 | |
---|---|---|
Buy | 1 | |
Outperform | 5 | |
Hold | 1 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 6 analysts offering 12 month price targets for Repare Therapeutics Inc have a median target of 9.50, with a high estimate of 25.00 and a low estimate of 8.00. The median estimate represents a 219.87% increase from the last price of 2.97.
High | 741.8% | 25.00 |
Med | 219.9% | 9.50 |
Low | 169.4% | 8.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Mar 03, 2025.
Average growth rate | -23.83% |
Average growth rate | -51.32% |
More ▼
Revenue history & estimates in USD
Average growth rate | +152.00% |
Average growth rate | +2,367.67% |
More ▼